PTC Therapeutics Raises Revenue Outlook as Sephience Drives 36% Quarterly Growth and Pipeline Advances
Market Chameleon (Fri, 8-May 11:21 AM)
PTC Therapeutics Grants Stock Options and RSUs to New Hires Under Nasdaq Rule 5635(c)(4)
Market Chameleon (Mon, 16-Mar 8:42 AM)
